# Federal Register #2026-21838

FDA Draft Guidance on U.S.-Origin Statements for Seafood Labels

**Buyer:** Department of Health and Human Services / Food and Drug Administration
**Posted:** October 27, 2026
**Respond By:** December 29, 2026
**Identifier:** 2026-21838

The FDA has announced draft guidance on U.S.-origin claims for seafood labels, not a request to buy products or services.
- **Government buyer:** No buyer or procurement is identified. The Food and Drug Administration (FDA), within the Department of Health and Human Services, issued the guidance.
- **OEMs and vendors:** None named; no products or services are being solicited.
- **Guidance scope:** Examples of U.S.-origin statements FDA would consider truthful and not misleading for single-ingredient seafood and seafood components in multi-ingredient foods.
- **Notable considerations:** The guidance is nonbinding. Businesses choosing to make U.S.-origin statements should be able to substantiate them.
- **Estimated labeling impact:** FDA estimates voluntary relabeling could involve 1,150 firms revising five labels each, for 5,750 label revisions and $7,664,750 in capital costs; this is not a contract value.

### Description

The FDA announces the availability of draft guidance entitled “U.S.-Origin Statements on Seafood.” When finalized, the guidance will provide examples of U.S.-origin statements in seafood product labeling that FDA would consider truthful and not misleading. The guidance covers single-ingredient seafood and seafood components of multi-ingredient foods; it is nonbinding and respondents choosing to use such statements should be able to substantiate them. Comments are due December 28, 2026.

[View original listing](https://www.federalregister.gov/documents/2026/10/27/2026-21838/us-origin-statements-on-seafood-draft-guidance-for-industry-availability)